Aucta aims to become a significant specialty pharma player in the U.S. and China marketplace. 

Since our founding, we have been focusing on building a company with sustainability by:   

•   Generating revenue every year

•   Allocating capital to produce respectable investment returns

•   Growing the company organically and continuously to generate product ideas and IP internally

•   Building a portfolio with clear therapeutic focuses

•   Assembling an energetic, dedicated, and experienced team who share our vision 

Our vision is to become a fully integrated specialty pharma company, discovering, developing, and commercializing our own products in both the United States and China.  We will continue to develop internal capabilities and technologies that are platform based, which can be extended to a series of products. We will build both internally and through collaborations with leading academic institutions and other innovative companies, discovering capabilities to continue to generate ideas to drive long term growth of the company.  Aucta also plans to establish a specialized commercial team to support marketing of our products in United States in the area of epilepsy and other specialty drugs.